Ttbio Corp. (TPEX:6493)
17.85
+0.35 (2.00%)
Jun 9, 2025, 12:18 PM CST
Ttbio Revenue
In the year 2024, Ttbio had annual revenue of 312.12M TWD, down -1.88%. Ttbio had revenue of 179.80M in the half year ending December 31, 2024, a decrease of -21.60%.
Revenue
312.12M
Revenue Growth
-1.88%
P/S Ratio
1.35
Revenue / Employee
2.65M
Employees
118
Market Cap
420.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 312.12M | -5.97M | -1.88% |
Dec 31, 2023 | 318.09M | -100.79M | -24.06% |
Dec 31, 2022 | 418.88M | 113.37M | 37.11% |
Dec 31, 2021 | 305.52M | 126.56M | 70.72% |
Dec 31, 2020 | 178.96M | -87.62M | -32.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 20.87B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 87.67M |
Lumosa Therapeutics | 43.59M |
Center Laboratories | 1.63B |
Oneness Biotech | 117.33M |